Seagoe company Almac is to create 180 jobs with the opening of its first facility in England.
The pharmaceutical firm said it would operate from “a significant proportion” of the 70-acre Charnwood campus in Loughborough.
Charnwood was formerly an R&D base for the global pharmaceutical group AstraZeneca.
Almac will occupy the formulation, development and analytical testing facilities.
The company said the site would complement existing development and manufacturing services in Seagoe.
It anticipates that the new jobs will be created over the next five years.
The initial investment into the Charnwood site will amount to £16m with an operational start date of early 2017.
Graeme McBurney, managing director, Almac Pharma Services commented, “As we experience increased client demand for our pharmaceutical development and niche commercial manufacturing services, this latest expansion will significantly enhance Almac’s offering, increasing capacity and capability and further demonstrating our continued commitment to support our global clients in the development and manufacturing of their drug products.”
Almac employs 4,000 people worldwide with more than half at Seagoe.
It is one of Northern Ireland’s leading exporters and also has bases in the United States and Singapore.